NCT03728153View on ClinicalTrials.gov

Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 26, 2019

Primary Completion Date

January 6, 2021

Study Completion Date

January 6, 2021

Conditions
Acute StrokeStroke, Ischemic
Interventions
DRUG

Fluoxetine 20 MG Oral Tablet

Once-daily dosing for 90 days

Trial Locations (1)

Unknown

Muhimbili National Hospital, Dar es Salaam

All Listed Sponsors
collaborator

Muhimbili University of Health and Allied Sciences

OTHER

lead

Massachusetts General Hospital

OTHER

NCT03728153 - Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania | Biotech Hunter | Biotech Hunter